About

ICCRT2020

For years now, cancer is the leading cause of death across the globe. Researchers have led meticulous studies focused on how to stop this deadly disease progression from it’s tracks. But the question is How close are we so farElix Techno Media bringing up a first of its kind International Conference on Cancer Research and Therapy ‘ICCRT’,  in Singapore City, Singapore to experience the cutting edge research on oncology, including the use of new era technology like AI, Robotic Surgical Techniques, Novel Therapeutics, Bio-therapy, Wearable, and other areas of innovation.

ICCRT 2020 unites researchers with diverse expertise in cancer research along with oncologists to discuss most intensively pursued topics of investigation. The aim and goal of the conference is to bridge basic and clinical aspects of the genesis, progression, prognosis, prevention, and treatment of cancer. The conference is focused upon disease management, prevention, strategies for early diagnosis, and specific classes of therapeutic agents, results of a clinical trial, an emerging international technique, supportive care, and rehabilitation/reconstruction.

The ICCRT 2020 program will take you beyond anything you have ever experienced before. You will see the technological and scientific discoveries that are disrupting the traditional constructs and forever changing the future of oncology.

Topics for sessions include, but are not limited to, the following:

Cancer is to a large extent avoidable. Many cancers can be prevented. Primary prevention encompasses the elimination or reduction of exposure to recognized risk factors in susceptible populations to prevent a disease. Evidence of effective primary prevention measures in reducing cancer rates are, for example, the observed decrease in cases of male lung cancer from a fall in tobacco smoking or reduced bladder cancer among dye workers after the elimination of aromatic amine exposures. Primary prevention is an important means to improve public health, and it is by far the most cost-effective and sustainable intervention for reducing the burden of cancer globally.

The last ten years have seen remarkable progress in cancer research. However, despite significant breakthroughs in the understanding, prevention, and treatment of cancer, the disease continues to affect millions of people worldwide. Cancer’s complexity compounded with financial, policy and regulatory roadblocks has slowed the rate of progress being made against cancer.

Screening in both healthy and high-risk populations offers the opportunity to detect cancer early and with an increased opportunity for treatment and curative intent. Currently, a defined role for screening exists in some cancer types, but each screening test has limitations, and improved screening methods are urgently needed. Unfortunately, many cancers still lack effective screening recommendations, or in some cases, the benefits from screening are marginal when weighed against the potential for harm.

The sustainability of cancer healthcare interventions and change programmers is of increasing importance to researchers and healthcare stakeholders interested in creating sustainable health systems to cope with mounting stressors. So the need of the hour is to extend earlier work and describe a systematic review to identify, synthesize and draw meaning that measure the sustainability of interventions, improvement efforts and change strategies in the cancer health system.

Palliative care has been increasingly shown to improve patient outcomes, in particular symptom management, quality of life and patient and family satisfaction. This has been shown within the care of people with cancer, but the methods by which palliative care is introduced earlier in the diagnosis is still complex. There are different models of increasing integration—care solely by the specialist, referral to other professionals or members of the team as necessary or an integrated model where palliative care interventions occur early in the disease progression.

With an increasing global cancer burden governments and NGOs alike are struggling to meet current and future cancer patient needs. Public–private partnerships (PPPs) are suggested as a way to improve outcomes but receive a mixed welcome due to differing working practices between partners and conflict of interest concerns.

Despite decreases in the cancer death rates in high-resource countries, such as the USA, the number of cancer cases and deaths is projected to more than double worldwide over the next 20–40 years. By 2030, it is projected that there will be ∼26 million new cancer cases and 17 million cancer deaths per year. The projected increase will be driven largely by growth and aging of populations and will be largest in low- and medium-resource countries. Foremost among these are the need to strengthen efforts in international tobacco control and to increase the availability of vaccines against hepatitis B and human papillomavirus (HPV) in countries where they are most needed.

Visit
Present
Learn
Understand
Previous
Next
Meet
Grow
Engage
Explore
Previous
Next

Endorsed by

Visit
Present
Learn
Understand
Previous
Next

Supporting Publications

All accepted abstracts for ICCRT 2020 will be published in the conference proceedings with an associated journal.

Meet
Grow
Engage
Explore
Previous
Next
  • Understand the present research and industry dynamics
  • Learn from experts
  • Get an open space to present your latest research findings
  • Associate with transformative technologies
  • Meet international colleagues
  • Build your customer base and establish your brand
  • Get recognized and acknowledged
  • Publish your research findings and case studies
  • Experience our state of the art hospitality and embrace the cultural diversity

A great occasion to interact with your peers both from academia and industry:

  • Researchers & Innovators
  • Thought Leaders and Decision Makers
  • Professionals Looking for Collaborations
  • Product and Technology Developers
  • Solution Providers
  • Associations, Societies, & Professional Bodies
  • Funding Agencies & Fund Raisers

Get your research published with us in the form of  Conference Proceedings with a DOI Number (DOI prefix: 10.37937).

  • To be a part of reviewing panel
  • To be a publication support

Contact us at: contact@elixtechnomedia.com